Falling coal prices prompt Queensland to accelerate shift into diversified resources; Explorers gain active support from ...

Trans-Tasman drug developer Aft Pharmaceuticals is targeting lucrative niche diseases its Big Pharma rivals have ignored ...

One ASX junior well placed to benefit from increasing bauxite demand from non-Guinea sources is Western Yilgarn.

The ASX has posted a 0.56pc gain in today’s trade, lifted by upward momentum in banking, tech and copper stocks.

Macquarie Bank has fast-tracked passing on the RBA rate cut to its customers, laying down a challenge to big four rivals.

In large caps news, Telstra (ASX:TLS) dipped 0.5% after unveiling a new five-year plan. TLS is lifting its return-on-invested-capital target to 10% by 2030, up from 8%, and wants earnings to grow ...

Brazilian Critical Minerals (ASX:BCM) has recorded a significant influx of solution in the first injection trial at the Ema project.

Optiscan (ASX:OIL) has successfully wrapped up the minimum viable product phase for its cloud-based telepathology software.

Optiscan and its Canadian partner have advanced in developing software that'll enable surgeons to 'talk' to remote pathologists in real time.

American West Metals (ASX:AW1) has raised almost $6 million to add to its funding pool to advance the Storm project in Canada.

The ASX made something of an erratic start on Tuesday. There are potential tailwinds ahead, however, when Wall Street opens ...

Good morning! Here’s everything you need to know before the ASX flings open its doors and begins trading today.